ArticleCells2023

Cardiovascular Protective Effects of NP-6A4, a Drug with the FDA Designation for Pediatric Cardiomyopathy, in Female Rats with Obesity and Pre-Diabetes.

Anthony M Belenchia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.